Global Cardiovascular Implants Market Growth 2023-2029

Global Cardiovascular Implants Market Growth 2023-2029

Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.

LPI (LP Information)' newest research report, the “Cardiovascular Implants Industry Forecast” looks at past sales and reviews total world Cardiovascular Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Implants sales for 2023 through 2029. With Cardiovascular Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Implants industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Implants.

The global Cardiovascular Implants market size is projected to grow from US$ 17000 million in 2022 to US$ 22670 million in 2029; it is expected to grow at a CAGR of 22670 from 2023 to 2029.

The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Implants market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Coronary Stents
Peripheral Stents
Heart Valves
Implanted Cardiac Pacemakers
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT) Device

Segmentation by application
Minimally Invasive Heart Surgery
Heart Valve Repair or Replacement
Cardiac Resynchronization Therapy (CRT)
Open Heart Surgery
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Boston Scientific
Medtronic
Abbott

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Implants market?

What factors are driving Cardiovascular Implants market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Implants market opportunities vary by end market size?

How does Cardiovascular Implants break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.